Achmea Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-6,036
| Closed | -$653K | – | 594 |
|
|
2019
Q4 | $653K | Hold |
6,036
| – | – | 0.03% | 419 |
|
|
2019
Q3 | $591K | Hold |
6,036
| – | – | 0.02% | 414 |
|
|
2019
Q2 | $791K | Hold |
6,036
| – | – | 0.03% | 397 |
|
|
2019
Q1 | $816K | Hold |
6,036
| – | – | 0.03% | 355 |
|
|
2018
Q4 | $588K | Hold |
6,036
| – | – | 0.03% | 369 |
|
|
2018
Q3 | $839K | Hold |
6,036
| – | – | 0.03% | 380 |
|
|
2018
Q2 | $749K | Hold |
6,036
| – | – | 0.03% | 397 |
|
|
2018
Q1 | $672K | Hold |
6,036
| – | – | 0.02% | 423 |
|
|
2017
Q4 | $721K | Buy |
6,036
+1,022
| +20% | +$122K | 0.02% | 419 |
|
|
2017
Q3 | $703K | Hold |
5,014
| – | – | 0.04% | 368 |
|
|
2017
Q2 | $610K | Hold |
5,014
| – | – | 0.04% | 386 |
|
|
2017
Q1 | $608K | Buy |
+5,014
| New | +$608K | 0.03% | 421 |
|